
While it’s long been known that oxytocin promotes feelings of love, social bonding, and wellbeing, only recently have scientists discovered it’s link to anxiety-producing bad memories.

Published in Anesthesiology, Eugene Silinsky, PhD, has found that calcium channels, and not a depletion of neurotransmitters as previously thought, are responsible for the decreased response in muscles treated by neuromuscular blockers. The finding could prove helpful in developing new therapies for a host of neuromuscular diseases.

In the first step toward animal-to-human transplants of insulin-producing cells for people with type 1 diabetes, Northwestern Medicine® scientists have successfully transplanted islets, the cells that produce insulin, from one species to another. And the islets survived without immunosuppressive drugs.

Published in the Journal of the American Medical Association, scientists determined that patients with coronary artery disease and regional myocardial wall thinning often have only limited scarring.

The Research on Adverse Drug Events and Reports project issued reports on 33 serious adverse drug or device reactions in its first decade of existence, showing its value as an independent drug surveillance program.

Published in the Journal of Clinical Investigation, the lab of Kathleen Green, PhD, has discovered desmoglein 1’s role in promoting the skin’s differentiation program.

New study finds that murderers who kill impulsively, often out of rage, and those who carefully carry out premeditated crimes differ markedly both psychologically and intellectually.

More suspected stroke victims received emergency care and potentially life-saving treatments in Chicago’s stroke centers thanks to a 2011 policy change under the Illinois Primary Stroke Center Act.

The annual International Science of Team Science Conference brought investigators from Asia, Europe, and North America together to learn how best to engage in the application of Team Science.

A new class of experimental drug-like small molecules is showing great promise in targeting a brain enzyme to prevent early memory loss in Alzheimer’s disease.